| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |